Cystitis Clinical Trial
Official title:
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis
Multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of XC243 in patients with exacerbation of chronic cystitis. It is planned to include patients with chronic cystitis in 4 parallel groups, who will receive XC243 at a dose of 25 mg per day, 50 mg per day, 75 mg per day or placebo for 7-10 days. Efficacy will be assessed by time from first study treatment to resolution of the symptom "Pain, discomfort or burning when urination " assessed on a visual-analog scale (VAS).
The study will be conducted in 8 centers. The study will include the following periods: screening (1 day), treatment period (up to 10 days), follow-up period (7 days). Upon completion of screening, patients will be randomized to 4 groups in the ratio 1:1:1:1: XC243 at a dose of 25 mg per day, 50 mg per day, 75 mg per day or placebo group. Also, all patients will be prescribed furasidin daily at the same time, 2 capsules (total dose 100 mg) 3 times a day after meals. On day 8 the investigator will assess the symptoms of cystitis and decide whether to discontinue or prolong a course of therapy with XC243 and furasidin for up to 10 days. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT00361998 -
Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated Cystitis
|
Phase 4 | |
| Completed |
NCT03275623 -
Management of Sub-Clinical Bacteriuria in Pregnancy
|
Phase 4 | |
| Not yet recruiting |
NCT05055544 -
Bearberry in the Treatment of Cystitis
|
N/A | |
| Active, not recruiting |
NCT01966653 -
Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women
|
Phase 4 | |
| Withdrawn |
NCT01527019 -
Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)
|
Phase 3 | |
| Completed |
NCT03877289 -
Efficacy of Oxybutynin in Paediatric Cystitis
|
Phase 4 | |
| Completed |
NCT05584657 -
Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women
|
Phase 3 | |
| Terminated |
NCT00164099 -
The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study
|
Phase 4 | |
| Completed |
NCT00528476 -
Risk Factors for Recurrent Urinary Tract Infection in Children
|
N/A | |
| Completed |
NCT04987164 -
Incidence of Cystitis in Women Consuming a Mixture of Cranberry, Cinnamon, Probiotics
|
||
| Completed |
NCT01861353 -
Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children
|
N/A | |
| Completed |
NCT00957333 -
Effects of Ketamine on Human Bladders and Its Possible Mechanisms
|
N/A | |
| Completed |
NCT05945667 -
Efficacy and Safety of Uronext® in Women With Cystitis
|
N/A | |
| Recruiting |
NCT05360914 -
Hospital at Home for Elderly Acute Ill Patients
|
N/A | |
| Completed |
NCT04272281 -
Use of a Share Decision Making Tool in the Care of Acute Cystitis Without Risk of Complication in Primary Care
|
N/A | |
| Completed |
NCT03425396 -
Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis
|
Phase 2 | |
| Completed |
NCT05260554 -
Effect of Cranberry Extract on the Urinary System
|
||
| Unknown status |
NCT00622076 -
Postoperative Catheterization After Anterior Colporrhaphy
|
N/A | |
| Completed |
NCT00801021 -
Treatment and/or Prevention of Urinary Tract Infections
|
Phase 1 | |
| Terminated |
NCT01060254 -
A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain
|
Phase 2 |